Illustration of a visual field grid partially obscured by darkness, symbolizing glaucoma-related vision loss.

Glaucoma Detection: How the Visual Field Index Can Help

Reese Marlowe monogram
Reese Marlowe in Health & Wellness October 2026 • 5 min read.

"Advanced glaucoma and visual field testing: Understanding the Visual Field Index (VFI) and its role in monitoring vision loss."


Glaucoma quietly steals sight, often without noticeable symptoms until significant damage has occurred. This makes early detection and consistent monitoring essential. One of the key tools in managing glaucoma is the Humphrey Visual Field (HVF) test, which measures a person's peripheral vision. The results of this test are summarized by the Visual Field Index (VFI), a single percentage that indicates the overall health of your visual field.

The Visual Field Index (VFI) is a powerful metric used by eye doctors to track the progression of glaucoma. It works by assessing the percentage of visual function remaining, with 100% representing a normal visual field and 0% indicating complete loss of sight. By monitoring changes in the VFI over time, doctors can assess the effectiveness of treatment and make necessary adjustments to prevent further vision loss.

But what happens when glaucoma advances? A study published in Investigative Ophthalmology & Visual Science sheds light on how the VFI behaves in advanced stages of the disease, particularly when the Mean Deviation (MD) crosses the -20 decibel (dB) threshold. This is a critical point, as the algorithm used to calculate the VFI changes at this stage. Understanding these nuances can help patients and caregivers better interpret test results and work with their doctors to make informed decisions.

AI Search Multiple angles on this topic

Glaucoma as a Leading Cause of Irreversible Blindness

Glaucoma stands as one of the leading causes of irreversible blindness worldwide, receiving significant interest for developing innovations in eye care. Visual field (VF) testing is considered a cornerstone for diagnosing and managing the disease, representing one of the most vital sources of data in glaucoma care. Global indices such as Mean Deviation (MD), Pattern Standard Deviation (PSD), and Visual Field Index (VFI) are useful in diagnosing stages of glaucoma. Functional measurements from VF testing uniquely quantify a patient's visual status, making it an essential examination factor in the management of glaucoma patients.

Static Automated Perimetry and Progression Analysis

Static automated perimetry, exemplified by the Humphrey Field Analyzer (HFA), has become the clinical standard, offering a precise and reproducible method for quantifying visual field sensitivities indispensable for glaucoma detection and management. Timely detection of glaucomatous progression is crucial, but relatively modest agreement among practitioners supports the use of complementary methods such as event-based and trend-based analyses. Event-based analyses account for expected localized test–retest variabilities in sensitivity, while trend-based analyses help detect overall change over time. If progression is suspected on VF without other corroborating red flags, the gold standard is to confirm true progression with a repeat VF test.

From Qualitative Observations to Quantitative Perimetry

Early evaluations of the visual field were mostly qualitative, with systematic documentation of visual field patterns emerging over time. It was not until 1856 that Albrecht von Graefe developed quantitative visual field measurements, presenting visual field loss characteristic of glaucoma and publishing examples of losses associated with other conditions. The past 40 years have seen significant evolution in modern visual field testing, driven by technological advancements in hardware, software algorithms, and novel testing paradigms that have reshaped the approach to glaucoma care.

What is the Visual Field Index (VFI) and Why Does It Matter?

Illustration of a visual field grid partially obscured by darkness, symbolizing glaucoma-related vision loss.

The Visual Field Index (VFI) is essentially a summary of your entire visual field, translated into a single, easy-to-understand percentage. It's calculated using data from the Humphrey Visual Field (HVF) test, which maps out your sensitivity to light at various points in your field of vision. This test helps identify areas where you may be experiencing vision loss, even if you haven't noticed it yourself.

The VFI is calculated differently depending on the severity of glaucoma. When the mean deviation (MD) – another measure of visual field loss – is better than -20 dB, the VFI is based on the pattern deviation probability plot (PDPP). This plot highlights localized areas of visual field loss, taking into account a person's age-related decline in vision. However, when the MD crosses -20 dB, the VFI calculation switches to the total deviation probability plot (TDPP). This plot considers the overall reduction in visual sensitivity compared to a healthy, age-matched individual.

  • Early Detection: Helps identify early signs of vision loss, even before you notice symptoms.
  • Progression Monitoring: Tracks the rate of visual field loss over time, allowing for timely adjustments to treatment.
  • Treatment Effectiveness: Assesses whether current treatments are effectively slowing or halting the progression of glaucoma.
  • Informed Decisions: Provides valuable information for patients and doctors to make collaborative decisions about glaucoma management.
AI Search Multiple angles on this topic

Evaluating Central Vision and Detecting Deterioration

Evaluation of central vision in glaucoma is important due to its impact on patients' quality of life and activities of daily living such as reading, driving, and walking. The 10-2 visual field assessment remains a mainstay in the functional evaluation of central vision. Detecting deterioration of visual field sensitivity measurements is important for the diagnosis and management of glaucoma, and current research surveys the methods available for assessing progression.

Real-World Limitations of Visual Field Testing

Standard automated visual field testing remains the gold standard for functional evaluation in glaucoma, but it carries real-world limitations. Fields are often performed infrequently, and each exam has significant potential for patient-induced variability. Regional patterns of visual field loss may affect vision-related quality of life differently in people with glaucoma, though evidence across studies remains inconsistent. As a result of these challenges, subtle progression can go undetected for too long, potentially delaying necessary intervention.

Comparative Effectiveness of VF Indices

Different visual field indices offer distinct strengths and tradeoffs in glaucoma monitoring. The Mean Deviation (MD) provides an overall measure of field loss, while Pattern Standard Deviation (PSD) highlights localized defects, and the Visual Field Index (VFI) summarizes the overall visual field status as a single percentage. No single index captures all aspects of glaucomatous change, and clinical interpretation often relies on considering multiple metrics together to form a comprehensive picture of disease progression.

This shift in calculation method can sometimes lead to a noticeable change in the VFI, even if there hasn't been a significant change in your actual vision. The Investigative Ophthalmology & Visual Science study aimed to quantify this change and identify the factors that influence it.

What Does This Mean for Glaucoma Patients?

The Investigative Ophthalmology & Visual Science study highlights the importance of understanding how the VFI behaves, especially in advanced glaucoma. A sudden drop in VFI when the MD crosses -20 dB doesn't necessarily indicate a rapid worsening of the condition. Instead, it may be due to the change in the calculation algorithm. By being aware of this, patients can avoid unnecessary anxiety and work with their doctors to get an accurate assessment of their glaucoma progression. Using the correction formula from this study can be a tool to calculate change in VFI. Consistent monitoring and open communication with your eye care provider remain the best strategies for managing glaucoma and preserving your vision.

AI Search Multiple angles on this topic

GPA Software and Expert Consensus

Glaucoma Progression Analysis (GPA) software has been compared with expert consensus opinion in the detection of visual field progression in glaucoma. These comparisons help clarify how automated tools perform relative to experienced clinician judgment. The ongoing dialogue between software-based detection and expert evaluation continues to shape best practices in glaucoma monitoring.

AI and Deep Learning in Visual Field Prediction

Deep learning algorithms are being developed to improve estimation of rates of progression and prediction of future patterns of visual field loss in glaucoma. A generalized variational auto-encoder (VAE) has been trained to learn representations that support these predictions. SHAP-based analysis has provided critical insights into the most relevant features for glaucoma diagnosis, showing promise in assisting eye care practitioners through explainable AI tools.

Central vs. Global VF Progression and Quality of Life

Research is examining the differential impact of progression of central visual field and global visual field on vision-related quality of life. Understanding whether central or peripheral field loss has a greater effect on daily functioning is essential for prioritizing monitoring and treatment strategies. This work underscores the need to consider both central and global visual field changes when assessing the real-world burden of glaucoma.

Identifying Fast Progressors in Clinical Practice

Primary open-angle glaucoma (POAG) is a chronic, largely asymptomatic disease, making identification of eyes with fast functional deterioration essential to prevent irreversible vision loss. In real-world cohorts, fast progression is often defined using MD-based criteria, whereas the clinical profile and stage-dependent performance of visual field index (VFI)-defined criteria offer an alternative approach. Recognizing fast progressors early remains a critical challenge in routine glaucoma care.

What VFI adds-and what it can hide

VFI gives a more centrally weighted percentage summary than MD, but like other global indices it compresses spatial detail. A single trend can therefore describe overall decline while obscuring where changes occur.[1] [2]

The larger average VFI change in eyes crossing the MD threshold is consistent with the reported variability at that transition, not by itself proof that the underlying visual field worsened by the same amount. The comparison describes index behavior around the crossing, rather than establishing a universal conversion to actual vision loss.[3]

How VFI compares with other progression measures

Cataract opacity can affect field-test results, and VFI’s relative reliability after cataract extraction had an exception involving early glaucoma with cortical opacity. This makes lens opacity type and glaucoma severity relevant context for interpreting VFI, rather than evidence that the index is unaffected by cataract.[4]

When peripheral test points can no longer register further change, averaging across a 24–2 field may mask change at central points; a more finely resolved central field could make that change more apparent. This describes a measurement-resolution issue, not a direct comparison of patient outcomes.[5]

What remains uncertain about VFI interpretation

  • How well does a linear VFI projection represent eyes whose progression does not remain steady, given the index’s stated linearity assumption?[2]
  • How much of the variability near the MD crossing reflects the change in included probability values, and how much reflects other influences on serial field measurements?[3]
  • When peripheral points show no further detectable change, how often does higher-resolution central testing reveal change that a broader field average misses?[5]

Sources

  1. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Part 1: Supported by the EGS Foundation (pmc.ncbi.nlm.nih.gov)
  2. Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression (pmc.ncbi.nlm.nih.gov)
  3. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss. (pubmed.ncbi.nlm.nih.gov)
  4. Effect of Cataract Opacity Type and Glaucoma Severity on Visual Field Index. (pubmed.ncbi.nlm.nih.gov)
  5. Comparing Glaucoma Progression on 24-2 and 10-2 Visual Field Examinations (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the Visual Field Index (VFI), and how does it help in glaucoma management?

The Visual Field Index (VFI) is a single percentage derived from the Humphrey Visual Field (HVF) test that summarizes the overall health of your visual field. It ranges from 100% (normal vision) to 0% (complete vision loss). Eye doctors use the VFI to track the progression of glaucoma, assess treatment effectiveness, and make informed decisions about patient care. Monitoring changes in the VFI over time allows for timely adjustments to treatment plans, aiming to prevent further vision loss.

2

How is the Visual Field Index (VFI) calculated, and why does the calculation method change?

The VFI calculation uses data from the Humphrey Visual Field (HVF) test. When the Mean Deviation (MD) is better than -20 decibels (dB), the VFI is based on the pattern deviation probability plot (PDPP). This plot highlights localized areas of visual field loss. However, when the MD crosses -20 dB, the calculation switches to the total deviation probability plot (TDPP). This change considers the overall reduction in visual sensitivity. This shift in calculation method can influence the VFI, especially in advanced stages of glaucoma.

3

What is the significance of the Mean Deviation (MD) threshold of -20 dB in relation to the Visual Field Index (VFI)?

The -20 dB threshold of the Mean Deviation (MD) is a critical point in glaucoma management because it triggers a change in how the Visual Field Index (VFI) is calculated. When the MD is worse than -20 dB, the calculation method switches from the pattern deviation probability plot (PDPP) to the total deviation probability plot (TDPP). This shift can lead to a noticeable change in the VFI, even if the patient's vision hasn't significantly worsened. This change is important for patients and caregivers to understand to avoid misinterpreting test results.

4

How can understanding the Visual Field Index (VFI) calculation change help glaucoma patients?

Understanding how the Visual Field Index (VFI) is calculated, particularly when the Mean Deviation (MD) crosses the -20 dB threshold, is crucial for glaucoma patients. A sudden drop in VFI may not always mean a rapid worsening of the condition; it could be due to the change in the calculation method. This awareness helps patients avoid unnecessary anxiety and facilitates accurate assessments of glaucoma progression. Patients can then work with their doctors for informed decisions and consistent monitoring.

5

What are the key benefits of using the Visual Field Index (VFI) in managing glaucoma?

The Visual Field Index (VFI) offers several key benefits in glaucoma management. Firstly, it aids in early detection of vision loss, even before noticeable symptoms occur. Secondly, it helps in monitoring the progression of visual field loss over time, allowing for timely adjustments to treatment plans. Thirdly, it assesses the effectiveness of current treatments. Finally, the VFI provides valuable information for patients and doctors to make collaborative decisions about managing glaucoma, helping preserve vision and improving quality of life.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.